Copaifera officinalis (Fabaceae) Copaiba, Diesel Tree, Maracaibo Balsam
Copaifera officinalis is a resinous tree native to northern South America, notable as the first species of the genus to be described and as a source of copaiba oleoresin, a balsam with a long history of medicinal use in Amazonian and Andean traditional medicine . The species has attracted modern clinical research that is unusual for a copaiba species: a randomized controlled trial of copaiba oil suppositories for acute hemorrhoidal crisis reported efficacy and safety, and a double-blind trial of oral copaiba oil capsules for peptic ulcer compared healing against omeprazole . Preclinical work has characterized the antinociceptive action of the oil and its kaurenoic acid constituent through opioid-dependent mechanisms . The name Copaifera officinalis L. is the currently accepted binomial .
1. Taxonomic Insights
Species: Copaifera officinalis L.
Family: Fabaceae (Leguminosae, subfamily Detarioideae)
Genus: Copaifera
Basionym: Copaifera officinalis L., Species Plantarum, ed. 2: 557 (1762)
Synonyms: Copaiva officinalis (L.) Jacq.; Copaiba officinalis (L.) Kuntze; Copaifera jacquinii Desf. (nom. illeg. superfl.); Copaifera jacquiniana G.Don (orth. var.)
Nomenclatural note: The species was described by Linnaeus in 1762 and is accepted by Kew Plants of the World Online and the WFO Plant List . The synonym Copaifera jacquinii Desf. is a superfluous illegitimate name, and Copaiba officinalis (L.) Kuntze reflects an alternative generic placement that has not been adopted. No recent generic recircumscription has affected Copaifera in the manner that the Acacia split affected Vachellia jacquemontii.
Botanical Description
Copaifera officinalis is a resinous tree with paripinnate, glabrous, subcoriaceous leaves bearing two to four pairs of opposite or semi-alternate, elliptic-ovoid, glandular-punctate leaflets. Inflorescences are panicles with numerous whitish subsessile flowers; petals are absent, and four lanceolate sepals are pubescent within and glabrous outside. The fruit is an ovoid, compressed, coriaceous legume containing a single black seed partially covered by an aril . The species is semi-deciduous, with flowering beginning in September and peaking in November, and fruiting from November to April .
Distribution: Native from Venezuela to northeastern Brazil and eastern Bolivia, occurring in the seasonally dry tropical biome. In Colombia, it is recorded from Amazonia and Orinoquia at elevations of 200 to 500 metres . It is cultivated in Africa and has been reported from Puerto Rico and Hawaii .
Conservation Status: Predicted extinction risk is "not threatened" with confident assessment . In Venezuela, it is evaluated as Least Concern in the Red Book of Venezuelan Flora and is not under any threat category on the global IUCN list .
Etymology
The generic name Copaifera derives from the Tupi copaíba, meaning "tree that produces oil," referring to the oleoresin exudate. The specific epithet officinalis is Latin for "of the workshop" or "medicinal," indicating the species' recognized pharmaceutical value. Common names include Copaiba, Copaiba Balsam, Maracaibo Balsam, Jesuit's Balsam, and Diesel Tree .
2. Common Names
Scientific Name: Copaifera officinalis | English: Copaiba, Copaiba Balsam, Maracaibo Balsam, Jesuit's Balsam, Diesel Tree | Spanish: Copaiba, Palo de aceite, Árbol de aceite, Bálsamo de copaiba | Portuguese: Copaíba, Copaibí | Other: Amacey, Copahu Balsam, Para Balsam
3. Related Herbs from the Fabaceae Family
Copaifera officinalis belongs to the Fabaceae, a family of immense economic and ecological importance. Within Copaifera, several species produce oleoresins used in traditional medicine, though C. officinalis is distinctive for its clinical trial evidence.
Copaifera langsdorffii: A widely studied Brazilian species whose oleoresin has demonstrated gastroprotective and wound-healing activities in animal models.
Copaifera reticulata: An Amazonian species whose copaiba oil is used in traditional medicine for wound healing and leishmaniasis, with demonstrated antiparasitic activity .
The Fabaceae are characterized by the production of terpenoids, flavonoids, and in Copaifera, the distinctive sesquiterpene-rich oleoresins that give the genus its economic and medicinal importance.
4. Medicinal Uses: Summary of Primary and Secondary Actions
Primary Actions:
Anti-hemorrhoidal: A prospective, randomized, controlled trial in 60 patients with acute hemorrhoidal crisis compared copaiba oil suppositories (120 mg twice daily) with copaiba plus lidocaine and with prednisolone/cinchocaine. Clinical improvement and symptom disappearance were achieved without significant adverse effects; two patients experienced transient anal burning pain that did not require discontinuation. The authors concluded that copaiba oil suppositories are an effective and safe alternative for acute hemorrhoidal crisis .
Anti-ulcer (peptic ulcer): A phase II randomized, double-blind, parallel-group trial in 60 patients with confirmed peptic ulcer compared copaiba oil capsules (80 mg and 120 mg) with omeprazole 20 mg, using endoscopic evaluation before and after treatment. Healing rates were assessed, though the accessible abstract reports only the beginning of the results ("Se logró 65..."), limiting interpretation of comparative efficacy .
Antinociceptive: C. officinalis oil (10 mg/kg, intragastric) and its constituent kaurenoic acid (1 mg/kg) produced dose-dependent antinociception in the mouse tail-flick test, with effects reversed by naloxone, indicating opioid involvement. Both reduced capsaicin- and allyl isothiocyanate-induced nociception and produced anti-allodynic effects in the complete Freund's adjuvant model after acute or repeated administration for seven days. No adverse effects, genotoxicity, or mutagenicity were observed at the tested doses .
Secondary Actions:
Anti-leishmanial: Copaiba oil from Amazonian Copaifera species, including C. officinalis, has demonstrated antiparasitic activity against the amastigote form of Leishmania amazonensis, likely related to changes in cell membrane and mitochondria. The oil showed low cytotoxicity and genotoxicity and may interfere with immune response to infection while also having a healing effect .
Anti-inflammatory and wound healing: The oil is used in Amazonian traditional medicine as an anti-inflammatory ingredient and for ulcer healing, scarring, and leishmaniasis wounds . Leaf infusions are used for infections and wounds .
Medicinal Parts
Oleoresin (copaiba oil): The principal medicinal part, obtained from the trunk. It is the subject of the hemorrhoid and peptic ulcer clinical trials and the antinociceptive study .
Leaves: Used as infusions for infections and wounds in traditional medicine .
Seeds: The hexane extract contains squalene, tetradecane, hexadecane, campesterol, stigmasterol, beta-sitosterol, and fatty acids; coumarin was isolated from the ethyl acetate extract .
5. Phytochemistry
5.1 Oleoresin Composition
The oleoresin of Copaifera species consists mainly of sesquiterpenes, unlike conifer oleoresins which are dominated by monoterpenes and diterpenes . In C. officinalis seedlings, leaves contained 26 sesquiterpenes and stems contained 25, with cluster analysis estimating at least four terpene synthase genes involved in sesquiterpene production . Kaurenoic acid has been identified and quantified in the oil by HPLC-DAD .
5.2 Seed Constituents
The hexane extract of seeds yielded squalene, tetradecane, hexadecane, campesterol, stigmasterol, and beta-sitosterol. Major fatty acids were hexadecanoic, 9-octadecenoic, and octadecanoic acids; minor fatty acids included decanoic, eicosanoic, docosanoic, and tetracosanoic acids. Coumarin was isolated from the ethyl acetate extract .
6. Mechanisms of Action
6.1 Antinociceptive: Opioid-Dependent and TRP Channel Modulation
The antinociceptive mechanism of C. officinalis oil and kaurenoic acid was characterized in mice. The effect in the tail-flick test was reversed by naloxone, indicating involvement of the opioid system. Both the oil and kaurenoic acid reduced nociception caused by capsaicin (a TRPV1 agonist) and allyl isothiocyanate (a TRPA1 agonist), suggesting modulation of these ion channels. The anti-allodynic effect in the complete Freund's adjuvant model, maintained after repeated administration for seven days, indicates efficacy in a model of inflammatory pain .
6.2 Anti-leishmanial: Membrane and Mitochondrial Disruption
The antiparasitic activity of copaiba oil against L. amazonensis amastigotes is probably related to changes in the cell membrane and mitochondria. The oil showed low cytotoxicity and genotoxicity, and may also interfere with the immune response to infection while exerting a healing effect .
7. Traditional and Ethnobotanical Uses
7.1 Wounds, Ulcers, and Leishmaniasis Lesions
Formulation: Copaiba oil applied topically or used in preparations.
Preparation and Use: In Amazonian traditional medicine, copaiba oil is used for ulcer healing, scarring, and difficult-to-heal leishmaniasis wounds . Leaf infusions are used for infections and wounds .
Scientific Validation: The anti-leishmanial activity has been demonstrated in vitro, and the wound-healing and anti-inflammatory properties are supported by traditional use and preclinical data . Clinical trials specific to wound healing were not identified.
7.2 Inflammation and Pain
Formulation: Copaiba oil, internal or external use.
Preparation and Use: Used as an anti-inflammatory ingredient in Amazonian traditional medicine . The species has traditional uses as an analgesic, anti-inflammatory, and antiseptic .
Scientific Validation: The antinociceptive activity of the oil and kaurenoic acid has been demonstrated in animal models through opioid-dependent and TRP channel-related mechanisms .
7.3 Hemorrhoids and Peptic Ulcer
Formulation: Suppositories (hemorrhoids); oral capsules (peptic ulcer).
Preparation and Use: The clinical trials employed standardized preparations: 120 mg copaiba oil suppositories twice daily for hemorrhoids , and 80 mg or 120 mg copaiba oil capsules once daily before breakfast for peptic ulcer .
Scientific Validation: Both indications have been evaluated in randomized controlled trials, though the peptic ulcer trial results are incompletely reported in the accessible abstract .
8. Healing Recipes, Teas, Decoctions, and Practical Applications
No standardized healing recipes, teas, or decoctions specific to C. officinalis were identified in the available search results beyond the clinical trial preparations and traditional uses documented above.
9. Clinical Significance and Evidence Summary
9.1 Evidence Hierarchy by Activity
Anti-hemorrhoidal: Strong evidence from a randomized controlled trial in 60 patients with acute hemorrhoidal crisis. Copaiba oil suppositories produced clinical improvement without significant adverse effects . Independent replication would strengthen the evidence.
Anti-ulcer (peptic ulcer): Moderate evidence from a randomized, double-blind trial in 60 patients, but the accessible abstract reports only partial results, limiting interpretation of comparative efficacy against omeprazole .
Antinociceptive: Moderate evidence from in vivo animal studies with mechanistic characterization (opioid reversal, TRP channel involvement) .
Anti-leishmanial: Preliminary in vitro evidence with low cytotoxicity and genotoxicity .
9.2 Safety and Toxicology Data
The hemorrhoid trial reported no significant adverse effects; two patients experienced transient anal burning pain that did not require discontinuation . The antinociceptive study found no adverse effects, genotoxicity, or mutagenicity at tested doses . The anti-leishmanial study reported low cytotoxicity and genotoxicity . No systematic toxicological studies of C. officinalis oil were identified beyond these observations.
10. Safety and Toxicology
10.1 Toxicity Profile
Acute Toxicity: No acute toxicity data were identified for C. officinalis oil.
Clinical Safety: Clinical trials and animal studies have reported no significant adverse effects at tested doses .
10.2 Contraindications and Precautions
Pregnancy and Lactation: No data available. Avoid medicinal use in the absence of safety information.
Children: No data available.
Known Hypersensitivity: No specific hypersensitivity data were identified. Individuals with known allergy to Fabaceae family plants should exercise caution.
10.3 Potential Drug Interactions
No specific drug interaction data were identified. Theoretical interactions based on antinociceptive (opioid-related) or anti-inflammatory activity cannot be excluded.
11. Quality Control Parameters
11.1 Marker Compounds for Standardisation
Kaurenoic acid is an appropriate marker for the oleoresin, as it has been quantified by HPLC-DAD and associated with antinociceptive activity . Sesquiterpene profiling can serve as a chemotaxonomic and quality parameter, given the dominance of sesquiterpenes in the oleoresin .
11.2 Recommended Analytical Methods
High-performance liquid chromatography with diode array detection (HPLC-DAD) for kaurenoic acid quantification . Gas chromatography-mass spectrometry (GC-MS) for sesquiterpene profiling .
11.3 Suggested Specifications
For oleoresin intended for medicinal use, specifications for kaurenoic acid content and sesquiterpene profile should be established based on validated batches. Given the documented variability in Copaifera oleoresins, specifications should account for natural variation.
11.4 Adulteration and Market Quality Concerns
No specific adulteration concerns were identified for C. officinalis. However, as with other Copaifera species, oleoresin composition varies, and authentication by chemical profiling is advisable.
12. Cultivation and Sustainability
12.1 Growth Requirements
Climate: Tropical; native to seasonally dry tropical biomes .
Habitat: Deciduous and semideciduous forests, riparian forests, wooded savannas, and open savannas in Venezuela .
Soil: No specific data available.
Propagation: No specific data available.
12.2 Sustainable Harvesting
The oleoresin is obtained from the trunk, a renewable exudate that does not require felling the tree. No specific sustainable harvesting protocols were identified.
12.3 Conservation Status
Predicted extinction risk "not threatened" with confident assessment . Least Concern in Venezuela .
12.4 Ecological Role and Sustainability Challenges
The species is described as a slow-growing tree with a deep root system, resistant to drought and able to grow in disturbed areas . Its ornamental value and use in parks and gardens are noted . No specific sustainability challenges were identified.
13. Cultivar and Varietal Comparison
No infraspecific taxa or cultivars of C. officinalis were identified in the available search results.
14. Research Gaps and Future Directions
14.1 Critical Research Gaps
Peptic Ulcer Trial Results: The full results of the double-blind trial comparing copaiba oil with omeprazole were not accessible; publication of complete efficacy data is needed .
Independent Replication: The hemorrhoid trial results merit independent replication in a larger, multicenter setting .
Bioactive Compound Isolation: While kaurenoic acid has been identified as an antinociceptive constituent, other active compounds in the oil have not been systematically characterized.
Pharmacokinetics: No absorption, distribution, metabolism, or excretion data exist for any constituent.
14.2 Future Research Priorities
Hemorrhoid Clinical Development: The positive randomized trial supports further clinical development of standardized copaiba oil suppositories for acute hemorrhoidal crisis .
Peptic Ulcer Clinical Development: Full publication and independent replication of the peptic ulcer trial are needed before conclusions can be drawn about efficacy relative to omeprazole .
Antinociceptive Development: The opioid-dependent and TRP channel-modulating mechanisms of kaurenoic acid merit further preclinical evaluation for inflammatory pain .
15. Commercial Applications
15.1 Traditional and Folk Medicine
Copaiba oil is widely traded and used in South American folk medicine for inflammatory conditions, wound healing, and hemorrhoids .
15.2 Pharmaceutical Development
The clinical trial evidence for hemorrhoids and peptic ulcer provides a pathway for pharmaceutical development of standardized copaiba oil preparations.
15.3 Bioenergy (Diesel Tree)
The oleoresin can be used directly in a diesel engine, earning the species the common name "diesel tree." However, use as biodiesel is currently limited by the geographical distribution of Copaifera trees .
16. Related Plants for Further Study
Copaifera langsdorffii: A related species with gastroprotective and wound-healing preclinical data, useful for comparative studies of oleoresin pharmacology.
Copaifera reticulata: An Amazonian species with anti-leishmanial activity, providing a comparative context for the antiparasitic properties of C. officinalis oil .
17. Reference Literature
Primary Research
Efficacy and safety of Copaifera officinalis oil suppositories in acute hemorrhoidal crisis: prospective, controlled, randomized trial. Revista de Gastroenterología del Perú. 2013;33(1):93-100. This randomized controlled trial in 60 patients demonstrated efficacy and safety of copaiba oil suppositories .
Dalenogare DP, et al. Antinociceptive activity of Copaifera officinalis Jacq. L oil and kaurenoic acid in mice. Inflammopharmacology. 2019;27(4):829-844. This study demonstrates opioid-dependent antinociception and TRP channel modulation by the oil and kaurenoic acid .
Arroyo Acevedo JL, et al. Efecto cicatrizante del aceite de Copaifera officinalis (copaiba) en pacientes con úlcera péptica. Anales de la Facultad de Medicina. 2011;72(2):113-117. This phase II randomized, double-blind trial compared copaiba oil capsules with omeprazole for peptic ulcer healing .
Veiga Junior VF, et al. Constituintes das sementes de Copaifera officinalis L. Acta Amazonica. 2007;37(4). This study reports the chemical composition of hexane and ethyl acetate seed extracts .
Within-plant distribution and emission of sesquiterpenes from Copaifera officinalis. Plant Physiology and Biochemistry. 2009;47(11-12):1015-1021. This study characterizes sesquiterpene distribution and emission in seedlings and young trees .
Review
Brazilian Amazon Traditional Medicine and the Treatment of Difficult to Heal Leishmaniasis Wounds with Copaifera. This review documents traditional uses, phytochemistry, leishmanicidal activity, and toxicity of Amazonian Copaifera species including C. officinalis .
Taxonomic References
Plants of the World Online, Kew Science. Copaifera officinalis L. Provides accepted name, native range, and distribution .
WFO Plant List. Copaifera officinalis L. Provides accepted status and synonymy .
Colombian Plants made accessible (Kew). Copaifera officinalis L. Provides synonymy, distribution in Colombia, conservation assessment, and common names .
18. Disclaimer
Copaifera officinalis has clinical trial evidence for acute hemorrhoidal crisis and peptic ulcer, and preclinical evidence for antinociceptive and anti-leishmanial activities. However, the peptic ulcer trial results are incompletely reported in the accessible literature, and independent replication of the hemorrhoid trial is desirable.
This information is for educational and academic purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
The oil has not been systematically evaluated for safety during pregnancy, lactation, or in children. Avoid medicinal use in these populations in the absence of safety data.
Individuals with known hypersensitivity to Fabaceae family plants should exercise caution.
Proper identification and standardized preparations are essential, as Copaifera oleoresin composition varies among species and individual trees.
Always consult a qualified healthcare practitioner before using any plant for medicinal purposes.

Comments